Court documents: Pfizer tried to cover up negative study data

10/8/2008 | Boston Globe (tiered subscription model), The

Pfizer's top marketing officials sought to conceal trial results showing that Neurontin did not help patients with chronic nerve pain, according to internal documents and e-mails filed at a Boston court. The records were submitted as part of a possible class-action case against the drugmaker. Pfizer denied the claim, saying it reports study data "in an objective, accurate, balanced and complete manner."

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ
Chief Executive Officer
UCare Minnesota
Minneapolis, MN
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC